EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANK and RANKL expression in giant-cell tumour of bone



RANK and RANKL expression in giant-cell tumour of bone



Lancet. Oncology 11(6): 514-514




(PDF emailed within 0-6 h: $19.90)

Accession: 055333126

Download citation: RISBibTeXText

PMID: 20522381

DOI: 10.1016/S1470-2045(10)70076-0



Related references

Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 14(5): 913-918, 2007

Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. Plos One 8(3): E58361-E58361, 2013

RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Journal of Bone and Mineral Research 21(9): 1339-1349, 2006

PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone. Journal of Orthopaedic Research 30(6): 877-884, 2012

Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 106(4): 548-555, 2008

RANK, RANKL and OPG gene expression in bone from children with osteogenesis imperfecta. Calcified Tissue International 72(3): 270, March, 2003

Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone 34(3): 393-401, 2004

Discovery of osteoclast differentiation factor, RANKL Inhibition of bone resorption by blocking RANKL-RANK signaling. Japanese Journal of Pharmacology 88(Supplement 1): 17P, 2002

Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunological Reviews 208: 30-49, 2005

CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression. Journal of Cellular Biochemistry 110(2): 438-446, 2010

RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. American Journal of Clinical Pathology 117(2): 210-216, 2002

Expression of RANK and RANKL is altered in invasive carcinoma and bone metastasis of breast cancer. Journal of Bone & Mineral Research 17(Suppl 1): S411, September, 2002

RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells. International Journal of Oncology 28(1): 261-269, 2005

RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells. International Journal of Oncology 28(1): 261-269, 2006

The regulation and expression of TNF/TNF receptor family members OPG, RANKL and RANK in human bone lineage cells. International Journal of Molecular Medicine 10(Supplement 1): S37, 2002